Skip to main content

Table 1 Overview antihypertensive drugs included in the RHYME-RCT trial

From: The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trial

Antihypertensive drug [metabolite]

Minimal drug dose for inclusion (mg)

LLOD (μg/L) [25]

Amlodipine

5

17.1

Barnidipine

10

2.1

Bumetanide

1

4.0

Doxazosin

4

18.1

Enalapril

20

0.4

[Enalaprilat]

–

1.1

Hydrochlorothiazide

12.5

40.2

Irbesartan

150

7.7

Losartan

50

1.7

[Losartan-CA]

–

2.6

Metoprolol

50 CR or 25 mg two times daily (normal release)

0

Nifedipine

30

3.5

Perindopril

4

0.7

[Perindoprilat]

–

1.3

Spironolactone

12.5

5.2

[Canrenone]

–

26.8

Valsartan

80

21.3

  1. CA carboxylic acid; CR controlled release, LLOD lower limit of detection